Early Edge: Wells Fargo & Company, Omeros Corporation, and Solazyme, Inc.

Stocks making headlines include Wells Fargo & Co (WFC), Omeros Corporation (OMER), and Solazyme Inc (SZYM)

by Andrea Kramer

Published on Apr 14, 2015 at 10:40 AM
Updated on Apr 20, 2015 at 5:32 PM

Despite signaling a higher open, the major market indexes are in the red, as traders digest the latest round of big-cap earnings. Among the equities making an early splash on the Street are financial concern Wells Fargo & Co (NYSE:WFC), pharmaceutical issue Omeros Corporation (NASDAQ:OMER), and renewable energy firm Solazyme Inc (NASDAQ:SZYM).

  • Like sector peer JPMorgan Chase & Co. (NYSE:JPM), WFC is fresh out of the earnings confessional. The firm reported stronger-than-expected per-share earnings and in-line revenue, and said mortgage banking revenue rose for the first quarter in five. Nevertheless, WFC is down 1.4% at $53.81, much to the dismay of a fresh crop of option bulls. Wells Fargo & Co is now testing support atop its 10-month moving average, which has ushered the equity higher since early 2012.

  • OMER is up 1.1% at $25.83, after European regulators approved the firm's OMS721 for compassionate use for thrombotic microangiopathy patients. In addition, Omeros Corporation is presenting at the Needham Healthcare Conference in New York today. The stock touched an intraday peak of $26.64 -- within a point of its record high, tagged on March 5 -- and the equity's ascent could have short sellers jittery. Short interest soared 36.6% during the past two reporting periods, and now represents almost 24% of OMER's total available float. It would take more than 17 sessions to buy back these bearish bets, at the equity's average pace of trading -- plenty of fuel for a short squeeze to propel the shares higher.

  • SZYM has rocketed 13.4% higher to $3.64, after the company announced a strategic agreement to develop and market Flocapso -- a drilling fluid additive -- with Flotek Industries Inc (NYSE:FTK). As with OMER, SZYM shorts could be running scared, as short interest represents nearly 25 sessions' worth of pent-up buying demand, at the stock's average daily volume. Likewise, option bears could hit the bricks. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security's 10-day put/call volume ratio of 2.47 ranks in the 97th percentile of its annual range. In other words, option buyers have picked up Solazyme Inc puts over calls at a much faster-than-usual clip during the past two weeks.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

The Top Lithium Play of 2020
Click to continue to advertiser's site.
First Week in April Provides More Coronavirus-Related Volatility
A slew of coronavirus-related news sent markets on another weekly roller coaster ride
Netflix Stock Heading into Historically Bullish Quarter
NFLX's 10-day moving average has stepped up as support lately
The Top Lithium Play of 2020
Click to continue to advertiser's site.